Charles Faith L. Insider Trades

Insider Trading History

Track insider trading activity for Charles Faith L.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Director
Holding Value $37.5k 7,100 shares
Last Trade
May 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$34k 7,100 shares
$4.79
$5.28
Abeona Therapeutics
Abeona Therapeutics ABEO
Director
Holding Value $1.03M 176,407 shares
Last Trade
Jan 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 37,313 shares
$5.19
$5.82
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Director
Holding Value $8.01k 1,517 shares
Last Trade
Nov 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.2k 1,517 shares
$6.70
$5.28
Abeona Therapeutics
Abeona Therapeutics ABEO
Director
Holding Value $810k 139,094 shares
Last Trade
Jul 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.9k 10,738 shares
$5.86
$5.82
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $140k 165,238 shares
Last Trade
Apr 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 115,194 shares
$11.70
$0.85
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $1.55k 165,238 shares
Last Trade
Apr 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35k 115,194 shares
$0.01
$0.01
Murphy Canyon Acquisition
Murphy Canyon Acquisition MURF
Director
Holding Value $2.78M 165,238 shares
Last Trade
Apr 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.94M 115,194 shares
$16.85
$16.85
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $2.74M 165,238 shares
Last Trade
Apr 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.88M 115,194 shares
$16.36
$16.56
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $42.5k 50,044 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$622k 46,629 shares
$13.35
$0.85
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $470 50,044 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499 46,629 shares
$0.01
$0.01
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $829k 50,044 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$763k 46,629 shares
$16.36
$16.56
Murphy Canyon Acquisition
Murphy Canyon Acquisition MURF
Director
Holding Value $843k 50,044 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$786k 46,629 shares
$16.85
$16.85
Abeona Therapeutics
Abeona Therapeutics ABEO
Director
Holding Value $872k 149,832 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 36,101 shares
$5.54
$5.82
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $6.96M 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.87M 420,000 shares
$16.36
$16.56
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $357k 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7M 420,000 shares
$106.50
$0.85
Murphy Canyon Acquisition
Murphy Canyon Acquisition MURF
Director
Holding Value $7.08M 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.08M 420,000 shares
$16.85
$16.85
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $3.95k 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.24k 420,000 shares
$0.01
$0.01
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $290k 341,594 shares
Last Trade
Nov 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$294M 266,594 shares
$1,102.80
$0.85
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $5.66M 341,594 shares
Last Trade
Nov 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.36M 266,594 shares
$16.36
$16.56
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $3.21k 341,594 shares
Last Trade
Nov 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.19k 266,594 shares
$0.01
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up